Concerning anaphylaxis medications in schools.

Looking ahead

No hearings or votes scheduled.

History

1. 2026
   1. Mar 12By resolution, returned to Senate Rules Committee for third reading.Latest
   2. Mar 4Rules Committee relieved of further consideration. Placed on second reading.Minor
   3. Feb 25Referred to Rules 2 Review.Minor
   4. Feb 23ED - Majority; do pass with amendment(s).Minor
   5. Feb 23Executive action taken in the House Committee on Education at 1:30 PM.
   6. Feb 18Public hearing in the House Committee on Education at 10:30 AM.
   7. Jan 26First reading, referred to Education.Minor
   8. Jan 21Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.Minor
      • Vote recorded Final Passage (#16). Result: pass.Upper
   9. Jan 13Placed on third reading by Rules Committee.Minor
   10. Jan 12By resolution, reintroduced and retained in present status.
2. 2025
   1. Apr 27By resolution, returned to Senate Rules Committee for third reading.
   2. Mar 18Public hearing in the House Committee on Education at 4:00 PM.
   3. Mar 12First reading, referred to Education.Minor
   4. Mar 10Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.Minor
      • Vote recorded 3rd Reading & Final Passage (#16). Result: pass.Upper
   5. Mar 10Rules suspended. Placed on Third Reading.Minor
   6. Mar 101st substitute bill substituted (EDU 25).Major
   7. Mar 5Placed on second reading by Rules Committee.Minor
   8. Feb 12Passed to Rules Committee for second reading.
   9. Feb 11EDU - Majority; 1st substitute bill be substituted, do pass.Major
   10. Feb 11Executive action taken in the Senate Committee on Early Learning & K-12 Education at 8:00 AM.
   11. Jan 29Public hearing in the Senate Committee on Early Learning & K-12 Education at 10:30 AM.
   12. Jan 14First reading, referred to Early Learning & K-12 Education.Introduced